Application 761179
- Type
- BLA
- Sponsor
- JAZZ PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RYLAZE | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | INJECTABLE;INTRAMUSCULAR | 10MG/0.5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68727-900 | Rylaze | asparaginase erwinia chrysanthemi (recombinant)-rywn | Jazz Pharmaceuticals, Inc. | BLA | Current |
| 68727-900 | Rylaze | asparaginase erwinia chrysanthemi (recombinant)-rywn | Jazz Pharmaceuticals, Inc. | BLA | Current |
| 68727-900 | Rylaze | asparaginase erwinia chrysanthemi (recombinant)-rywn | Jazz Pharmaceuticals, Inc. | BLA | Current |
| 68727-900 | Rylaze | asparaginase erwinia chrysanthemi (recombinant)-rywn | Jazz Pharmaceuticals, Inc. | BLA | Current |